CORRESP 1 filename1.htm Correspondence Letter

 

LOGO

  

Sandra Leung

Senior Vice President, General Counsel & Corporate Secretary

  

 

345 Park Avenue      New York, NY 10154-0037

Tel 212-546-4260    Fax 212-546-9562

sandra.leung@bms.com

  

 

September 17, 2007

 

Michael Reedich, Special Counsel

United States Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

 

Re:   Bristol-Myers Squibb Company
  Definitive 14A
  Filed March 22, 2007
  File No. 1-01136

Dear Mr. Reedich:

Following up on our discussion today, this will confirm that Bristol-Myers Squibb Company has requested an extension to October 12, 2007 to respond to the comment letter we received regarding the above-referred filed document. This will also confirm that you have granted our request.

 

Sincerely,

/s/ Sandra Leung

Sandra Leung